Advanced Wound Care Market: Information by Product (Advanced Wound Dressings), Wound Type(Surgical and Traumatic Wounds), End-User(Hospitals), and Region — Forecast till 2029

Feb 18, 2021   The global advanced wound care market was estimated at USD 10,500 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period. The Rising Prevalence of Chronic and Surgical Wounds The rising prevalence of lifestyle disorders contributing to chronic wounds, such as diabetic foot ulcers (DFU), venous leg ulcers (VLU), and pressure ulcers (P.U.), is one of the primary key factors contributing to market growth. Advanced wound management is necessary for treating these chron...
Request Free Sample Report

Report Description

The global advanced wound care market was estimated at USD 10,500 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.

Advanced-Wound-Care-Market

The Rising Prevalence of Chronic and Surgical Wounds

The rising prevalence of lifestyle disorders contributing to chronic wounds, such as diabetic foot ulcers (DFU), venous leg ulcers (VLU), and pressure ulcers (P.U.), is one of the primary key factors contributing to market growth. Advanced wound management is necessary for treating these chronic ulcers, and as per a research study, less than 25% of DFUs and less than 30% of VLUs are effectually treated with the current standard of care treatment. An increase in the number of diabetic foot ulcers could create tremendous demand for advanced wound care products. For instance, in the U.K., the Independent Diabetes Trust (2019) reported that around 115,000 UK, people diabetic foot ulcers, and around 278,000 people are treated for venous leg ulcers annually.

BurgeoningGeriatric Population Coupled With the Rising Prevalence of Diabetes

Diabetes is a metabolic illness known to develop complications that do not typically recover independently and require surgery. Diabetic foot ulcers, for example, typically turn out to be contagious, and patients can end up with amputations at times. Advanced wound care dressings and instruments are useful in such situations to relieve patients' pain. According to the International Diabetes Federation (IDF), globally, more than 460 million people between 20 and 79 live with diabetes, and by 2045 this number is likely to rise to 700 million.

Advanced-Wound-Care-Market-Growth

Diabetes, rising patient age, and obesity are critical risk factors leading to the development of typical non-healing wounds such as DFUs, VLUs, and Pus. In the next 10 years, populations with these risk factors might proliferate significantly. Thus, with the mounting elderly population and the surge in obesity and diabetes, chronic wounds are projected to increase globally. There are now up to 1 billion people aged 60 and older, more than 2 billion overweight adults, and more than 500 million people with diabetes worldwide.

Global Advanced Wound Care Market: Segmentation

The Foam Dressing Segment is Projected to Register Robust GrowthUnder the Wound Dressings Segment

Usually, foam dressings are composed of polyurethane foam. While all-foam dressings are hydrophilic, with composite and thickness, their absorbent rates and absorbency vary. Any foam dressings have the capacity for up to 7 days of absorption. During the inflammatory process after debridement and sloughing, when drainage is at its height, foam dressings are primarily used for heavily exuding wounds. To avoid premature closing, they are often recommended for deep cavity wounds to sustain a moist atmosphere by absorbing exudate. The benefits such as moisture wound healing, non-adherent nature, and bacterial barrier are escalating the adoption of foam dressings.

Moreover, novel product launches and new development in dressings encouraged the segment growth over the forecast period. For instance, in May 2018, Coloplast U.S.'s Wound and Skin Care Division introduced Biatain Silicone with 3DFit Technology. Biatain Silicone also provides a full-range portfolio of foam dressings intended to provide healthcare practitioners flexibility in exuding wound control or pressure injury prevention. In April 2017, Convatec launched Foam Lite, a light, flexible silicone foam dressing to manage low to non-exuding chronic and acute wounds.

The HospitalSegment to Grow at Momentous Pace in Coming Years

A massive pool of patients suffering from chronic and acute wounds associated SSIs and HAIs and burn injuries receive treatment in hospitals. As per a research study, it is expected that 1·5–2 million people in Europe suffer from acute or chronic wounds. Several hospitals also outsource their wound care from companies to focus on their traditional departments that are a much higher percentage of their total operation. Other areas where wound care management firms help hospitals include: compression therapy, intravenous therapy, advanced dressings, wound debridement, nutritional counseling, lymphedema management, and diabetic education. For instance, Healogics has more than 700 wound care centers in 46 states and delivers care nationally at about 300 accredited nursing facilities. Every year, over 300,000 people undergo care through the Healogics Network. To advance inpatient wound management services, the firm has been partnering with hospital clients.

Nearly 7 million people, a projected 2% of the total U.S. population, entail care for chronic, non-healing wounds. Hyperbaric Oxygen Therapy (HBOT) is a treatment for non/slow-healing wounds. Foremost studies illustrate a 59% reduction in the size of wounds after only 30 days of treatment. Major hospitals such as CurtisCare specializes in treating a range of complex wounds with the use of HBOT.

Regional Overview

North-America-Lead-Advanced-Wound-Care-Market

Prevalence of Chronic Wound in North America

North America held the leading position in the global advanced wound care market in 2019, owing to the upsurge in chronic wounds' occurrence coupled with the mounting occurrence of diabetes. Statistically, according to reports published by the American Diabetes Association (ADA), in 2018, 34.2 million Americans constituting 10.5% of the population were estimated to have either type of diabetes. Further, the rise in the geriatric population was another critical cause corresponding to the same. The estimated number of people from the population group of 65 years and older who suffered clinical diabetic conditions were around 14.3 million, with a massive prevalence rate of 26.8%. 

Table 1: Estimated number of adults aged 18 years or older with diagnosed diabetes, undiagnosed diabetes, and total diabetes, United States, 2018

Characteristics

Diagnosed diabetes cases

(No. in Millions) (95% CI)

Undiagnosed diabetes cases

(No. in Millions) (95% CI)

Total cases

(No. in Millions) (95% CI)

Total

26.8

7.3

34.1

Age in Years

18-44

3.6

1.4

4.9

45-64

11.7

3.1

14.8

>65

11.5

2.9

14.3

Sex

Male

14.0

3.9

17.9

Female

12.8

3.4

16.2

Source- National Diabetes Statistics Report, U.S. Census Bureau 2018

Besides, Becker's Healthcare stated that more than 30 million diabetics and 28.4 million people with heart disease reside in the U.S. Both diseases represent public health epidemics and carry an intensified risk for chronic wound development. Nearly 6.7 million Americans are afflicted with chronic, non-healing wounds. As per the study conducted by the National Center for Biotechnology Information (NCBI) on Challenges in the Treatment of Chronic Wounds, in 2017, almost 2.4 million to 4.5 million individuals were affected with chronic lower extremity in the U.S ulcers wound in 2013. The Agency of Healthcare Research and Quality estimated that more than 2.5 million people in the U.S. develop pressure ulcers every year. Pressure ulcers are treated easily with advanced wound care products, which ultimately grow the market.

Advent of Novel Products in India

India’sadvanced wound care management market is expanding steadily and has created abundant opportunities to launch new products. For instance, in February 2019, MaxioCel, a next-generation wound care dressing made of chitosan in New Delhi, India, was unveiled by AxioBiosolutions, an India-based MedTech firm. The medication is intended to provide patients suffering from recurrent injuries such as pressure ulcers, diabetic foot ulcers, venous leg ulcers, cavity wounds, skin abrasions, and post-operative surgical wounds with relief and more comfortable recovery.

Furthermore, the strong presence of manufacturing facilities and local players such as Zywie Pharmaceuticals Pvt. Limited., Virchow Biotech Private Limited, Sangam Healthcare Products Ltd., Pradeep Surgical Dressings Private Limited., FibrohealWoundcare Pvt. Ltd., and many others are engaged in the manufacturing and distribution of advanced wound care management products in the region and throughout India.is adding up to the regional market expansion. For instance, Elkem South Asia Pvt Ltd. (A Bluestarcompany) has a manufacturing facility in Mumbai, and AxioBiosolutions, anaxiostat chitosan developer hemostatic dressing, has a manufacturing facility in Gujarat.

Competitive Landscape

Key strategies implemented by key players in the industry include acquisitions, mergers, distribution deals, and new product launches to strengthen the portfolio of products and capture a larger market share. For instance, in July 2018, Mölnlycke completed SastoMed GmbH, a German wound care firm, to extend its product range and specialized wound care business offerings.

Recent Developments

  • In March 2020, Smith and Nephew Plc.Launched PICO 14 Single-use NPWT device and dressings in the U.S.
  • In February 2020, Smith and Nephew Plc. opened a new high-technology production facility in BatuKawan Industrial Park in Malaysia.

Key Players

  • ConvaTec Group
  • Integra Lifesciences
  • Smith and Nephew
  • Coloplast Group
  • B. Braun Melsungen AG
  • 3M Group
  • Cardinal Health Inc.
  • Medline Industries
  • Zimmer Biomet
  • Paul HARTMANN
  • Mölnlycke Health Care AB
  • Others

Global Advanced Wound Care Market: Segmentation

By Product

  • Advanced Wound Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Film Dressings
    • Hydrocolloid Dressings
    • Collagen Dressings
    • Hydrofiber Dressings
    • Superabsorbent Dressings
    • Foam Dressings
    • Others
  • Wound Care Devices
    • Negative Wound Pressure Therapy (NPWT) Devices
    • Hyperbaric Oxygen Therapy (HOT) Devices
    • Extracorporeal Shock Wave Therapy (ESWT) Devices
    • Pressure Relief Devices
    • Other Devices
  • Active Wound Care Products
    • The Artificial Skin and Skin Substitutes
    • Biological Skin Equivalents
    • Growth Factors
  • Other Products

By Wound Type

  • Surgical and Traumatic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Burns
  • Other Wound Types

By End-User

  • Hospitals
  • Wound Care Centers
  • Homecare
  • Other End Users

By Region

  • America
  • Europe
  • Asia-Pacific
  • The Middle-East and Africa

Frequently Asked Questions (FAQs)

The rising prevalence of lifestyle disorders, rise in the geriatric population are the key factors expected to drive Advanced Wound Care Market during the forecast period.
In 2019 Global Advanced Wound Care Market was valued at USD 10,500 million.
ConvaTec Group, Integra Lifesciences, Smith and Nephew, Coloplast Group, B. Braun Melsungen AG, 3M Group, Cardinal Health Inc., Medline Industries, Zimmer Biomet, Paul HARTMANN, Mölnlycke Health Care AB are the top players in Advanced Wound Care Market.
North America is expected to hold the highest market share in Advanced Wound Care Market.
Foam Dressing Segment is expected to be the leading segment in Advanced Wound Care Market during the forecast period.
The global advanced wound care market was estimated at USD 10,500 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

The global advanced wound care market was estimated at USD 10,500 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.

Advanced-Wound-Care-Market

The Rising Prevalence of Chronic and Surgical Wounds

The rising prevalence of lifestyle disorders contributing to chronic wounds, such as diabetic foot ulcers (DFU), venous leg ulcers (VLU), and pressure ulcers (P.U.), is one of the primary key factors contributing to market growth. Advanced wound management is necessary for treating these chronic ulcers, and as per a research study, less than 25% of DFUs and less than 30% of VLUs are effectually treated with the current standard of care treatment. An increase in the number of diabetic foot ulcers could create tremendous demand for advanced wound care products. For instance, in the U.K., the Independent Diabetes Trust (2019) reported that around 115,000 UK, people diabetic foot ulcers, and around 278,000 people are treated for venous leg ulcers annually.

BurgeoningGeriatric Population Coupled With the Rising Prevalence of Diabetes

Diabetes is a metabolic illness known to develop complications that do not typically recover independently and require surgery. Diabetic foot ulcers, for example, typically turn out to be contagious, and patients can end up with amputations at times. Advanced wound care dressings and instruments are useful in such situations to relieve patients' pain. According to the International Diabetes Federation (IDF), globally, more than 460 million people between 20 and 79 live with diabetes, and by 2045 this number is likely to rise to 700 million.

Advanced-Wound-Care-Market-Growth

Diabetes, rising patient age, and obesity are critical risk factors leading to the development of typical non-healing wounds such as DFUs, VLUs, and Pus. In the next 10 years, populations with these risk factors might proliferate significantly. Thus, with the mounting elderly population and the surge in obesity and diabetes, chronic wounds are projected to increase globally. There are now up to 1 billion people aged 60 and older, more than 2 billion overweight adults, and more than 500 million people with diabetes worldwide.

Global Advanced Wound Care Market: Segmentation

The Foam Dressing Segment is Projected to Register Robust GrowthUnder the Wound Dressings Segment

Usually, foam dressings are composed of polyurethane foam. While all-foam dressings are hydrophilic, with composite and thickness, their absorbent rates and absorbency vary. Any foam dressings have the capacity for up to 7 days of absorption. During the inflammatory process after debridement and sloughing, when drainage is at its height, foam dressings are primarily used for heavily exuding wounds. To avoid premature closing, they are often recommended for deep cavity wounds to sustain a moist atmosphere by absorbing exudate. The benefits such as moisture wound healing, non-adherent nature, and bacterial barrier are escalating the adoption of foam dressings.

Moreover, novel product launches and new development in dressings encouraged the segment growth over the forecast period. For instance, in May 2018, Coloplast U.S.'s Wound and Skin Care Division introduced Biatain Silicone with 3DFit Technology. Biatain Silicone also provides a full-range portfolio of foam dressings intended to provide healthcare practitioners flexibility in exuding wound control or pressure injury prevention. In April 2017, Convatec launched Foam Lite, a light, flexible silicone foam dressing to manage low to non-exuding chronic and acute wounds.

The HospitalSegment to Grow at Momentous Pace in Coming Years

A massive pool of patients suffering from chronic and acute wounds associated SSIs and HAIs and burn injuries receive treatment in hospitals. As per a research study, it is expected that 1·5–2 million people in Europe suffer from acute or chronic wounds. Several hospitals also outsource their wound care from companies to focus on their traditional departments that are a much higher percentage of their total operation. Other areas where wound care management firms help hospitals include: compression therapy, intravenous therapy, advanced dressings, wound debridement, nutritional counseling, lymphedema management, and diabetic education. For instance, Healogics has more than 700 wound care centers in 46 states and delivers care nationally at about 300 accredited nursing facilities. Every year, over 300,000 people undergo care through the Healogics Network. To advance inpatient wound management services, the firm has been partnering with hospital clients.

Nearly 7 million people, a projected 2% of the total U.S. population, entail care for chronic, non-healing wounds. Hyperbaric Oxygen Therapy (HBOT) is a treatment for non/slow-healing wounds. Foremost studies illustrate a 59% reduction in the size of wounds after only 30 days of treatment. Major hospitals such as CurtisCare specializes in treating a range of complex wounds with the use of HBOT.

Regional Overview

North-America-Lead-Advanced-Wound-Care-Market

Prevalence of Chronic Wound in North America

North America held the leading position in the global advanced wound care market in 2019, owing to the upsurge in chronic wounds' occurrence coupled with the mounting occurrence of diabetes. Statistically, according to reports published by the American Diabetes Association (ADA), in 2018, 34.2 million Americans constituting 10.5% of the population were estimated to have either type of diabetes. Further, the rise in the geriatric population was another critical cause corresponding to the same. The estimated number of people from the population group of 65 years and older who suffered clinical diabetic conditions were around 14.3 million, with a massive prevalence rate of 26.8%. 

Table 1: Estimated number of adults aged 18 years or older with diagnosed diabetes, undiagnosed diabetes, and total diabetes, United States, 2018

Characteristics

Diagnosed diabetes cases

(No. in Millions) (95% CI)

Undiagnosed diabetes cases

(No. in Millions) (95% CI)

Total cases

(No. in Millions) (95% CI)

Total

26.8

7.3

34.1

Age in Years

18-44

3.6

1.4

4.9

45-64

11.7

3.1

14.8

>65

11.5

2.9

14.3

Sex

Male

14.0

3.9

17.9

Female

12.8

3.4

16.2

Source- National Diabetes Statistics Report, U.S. Census Bureau 2018

Besides, Becker's Healthcare stated that more than 30 million diabetics and 28.4 million people with heart disease reside in the U.S. Both diseases represent public health epidemics and carry an intensified risk for chronic wound development. Nearly 6.7 million Americans are afflicted with chronic, non-healing wounds. As per the study conducted by the National Center for Biotechnology Information (NCBI) on Challenges in the Treatment of Chronic Wounds, in 2017, almost 2.4 million to 4.5 million individuals were affected with chronic lower extremity in the U.S ulcers wound in 2013. The Agency of Healthcare Research and Quality estimated that more than 2.5 million people in the U.S. develop pressure ulcers every year. Pressure ulcers are treated easily with advanced wound care products, which ultimately grow the market.

Advent of Novel Products in India

India’sadvanced wound care management market is expanding steadily and has created abundant opportunities to launch new products. For instance, in February 2019, MaxioCel, a next-generation wound care dressing made of chitosan in New Delhi, India, was unveiled by AxioBiosolutions, an India-based MedTech firm. The medication is intended to provide patients suffering from recurrent injuries such as pressure ulcers, diabetic foot ulcers, venous leg ulcers, cavity wounds, skin abrasions, and post-operative surgical wounds with relief and more comfortable recovery.

Furthermore, the strong presence of manufacturing facilities and local players such as Zywie Pharmaceuticals Pvt. Limited., Virchow Biotech Private Limited, Sangam Healthcare Products Ltd., Pradeep Surgical Dressings Private Limited., FibrohealWoundcare Pvt. Ltd., and many others are engaged in the manufacturing and distribution of advanced wound care management products in the region and throughout India.is adding up to the regional market expansion. For instance, Elkem South Asia Pvt Ltd. (A Bluestarcompany) has a manufacturing facility in Mumbai, and AxioBiosolutions, anaxiostat chitosan developer hemostatic dressing, has a manufacturing facility in Gujarat.

Competitive Landscape

Key strategies implemented by key players in the industry include acquisitions, mergers, distribution deals, and new product launches to strengthen the portfolio of products and capture a larger market share. For instance, in July 2018, Mölnlycke completed SastoMed GmbH, a German wound care firm, to extend its product range and specialized wound care business offerings.

Recent Developments

  • In March 2020, Smith and Nephew Plc.Launched PICO 14 Single-use NPWT device and dressings in the U.S.
  • In February 2020, Smith and Nephew Plc. opened a new high-technology production facility in BatuKawan Industrial Park in Malaysia.

Key Players

  • ConvaTec Group
  • Integra Lifesciences
  • Smith and Nephew
  • Coloplast Group
  • B. Braun Melsungen AG
  • 3M Group
  • Cardinal Health Inc.
  • Medline Industries
  • Zimmer Biomet
  • Paul HARTMANN
  • Mölnlycke Health Care AB
  • Others

Global Advanced Wound Care Market: Segmentation

By Product

  • Advanced Wound Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Film Dressings
    • Hydrocolloid Dressings
    • Collagen Dressings
    • Hydrofiber Dressings
    • Superabsorbent Dressings
    • Foam Dressings
    • Others
  • Wound Care Devices
    • Negative Wound Pressure Therapy (NPWT) Devices
    • Hyperbaric Oxygen Therapy (HOT) Devices
    • Extracorporeal Shock Wave Therapy (ESWT) Devices
    • Pressure Relief Devices
    • Other Devices
  • Active Wound Care Products
    • The Artificial Skin and Skin Substitutes
    • Biological Skin Equivalents
    • Growth Factors
  • Other Products

By Wound Type

  • Surgical and Traumatic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Burns
  • Other Wound Types

By End-User

  • Hospitals
  • Wound Care Centers
  • Homecare
  • Other End Users

By Region

  • America
  • Europe
  • Asia-Pacific
  • The Middle-East and Africa

Frequently Asked Questions (FAQs)

The rising prevalence of lifestyle disorders, rise in the geriatric population are the key factors expected to drive Advanced Wound Care Market during the forecast period.
In 2019 Global Advanced Wound Care Market was valued at USD 10,500 million.
ConvaTec Group, Integra Lifesciences, Smith and Nephew, Coloplast Group, B. Braun Melsungen AG, 3M Group, Cardinal Health Inc., Medline Industries, Zimmer Biomet, Paul HARTMANN, Mölnlycke Health Care AB are the top players in Advanced Wound Care Market.
North America is expected to hold the highest market share in Advanced Wound Care Market.
Foam Dressing Segment is expected to be the leading segment in Advanced Wound Care Market during the forecast period.
The global advanced wound care market was estimated at USD 10,500 million in 2019 and is expected to grow at a 6.5% CAGR during the forecast period.
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times and included in every purchase.
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
Basically, choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.